News

Do Lasers or Topicals Really Work for Nonmelanoma Skin Cancers?

The precipitous increase in NMSCs, especially in younger patient populations, could translate into an alarming number of NMSCs as the population ages.


 

Lori Brightman, MD, Melanie Warycha, MD, Robert Anolik, MD, and Roy Geronemus, MD*

Novel strategies are urgently needed to address the millions of nonmelanoma skin cancers treated in the United States annually. The need is greatest for those patients who are poor surgical candidates or those prone to numerous nonmelanoma skin cancers and therefore at risk for marked disfigurement. Traditional treatment strategies include electrosurgery with curettage, radiation therapy, cryotherapy, excision, and Mohs micrographic surgery. Alternatives to traditional treatment, including topical medications and light or laser therapies, are becoming popular; however, there are various degrees of efficacy among these alternative tactics. These alternatives include topical retinoids, peels, 5-fluorouracil, imiquimod, photodynamic therapy, and lasers. The purpose of this paper is to review the available data regarding these alternative strategies and permit the reader to have a sense of which therapies are reasonable options for care.

*For a PDF of the full article, click on the link to the left of this introduction.

Recommended Reading

AAD: Cancer Patients With Skin Conditions Not Being Referred
MDedge Dermatology
New Options for Field Therapy: MAL-PDT Plus Red LED
MDedge Dermatology
Blog: Skin Cancer Screening RV Makes AAD Pit Stop
MDedge Dermatology
AAD: Melanoma Underreported to Cancer Registries
MDedge Dermatology
Percutaneous Hepatic Perfusion Boosts Melanoma Response
MDedge Dermatology
AAD: Skin Cancer Incidence Continuing to Rise
MDedge Dermatology
The Role of Targeted Molecular Inhibitors in the Management of Advanced Nonmelanoma Skin Cancer
MDedge Dermatology
Merkel Cell Carcinoma: Update and Review
MDedge Dermatology
Current Approaches to Skin Cancer Management in Organ Transplant Recipients
MDedge Dermatology
Update on the Management of High-Risk Squamous Cell Carcinoma
MDedge Dermatology